皮肤复发癌
| 药物 | 药物名称 | 药物的描述 |
|---|
| 药物 | 药物名称 | 目标 | 类型 |
|---|
| 药物 | 药物名称 | 阶段 | 状态 | 数 |
|---|---|---|---|---|
| DB00530 | 埃罗替尼 | 1 | 积极不招聘 | 1 |
| DB17467 | Interleukin-15,人类重组 | 1 | 完成 | 1 |
| DB09037 | Pembrolizumab | 1 | 未知的状态 | 1 |
| DB11740 | Adavosertib | 2 | 积极不招聘 | 1 |
| DB08916 | Afatinib | 2 | 积极不招聘 | 1 |
| DB11967 | Binimetinib | 2 | 积极不招聘 | 1 |
| DB12218 | Capivasertib | 2 | 积极不招聘 | 1 |
| DB12483 | Copanlisib | 2 | 积极不招聘 | 1 |
| DB08865 | Crizotinib | 2 | 积极不招聘 | 1 |
| DB08912 | Dabrafenib | 2 | 积极不招聘 | 1 |
| DB01254 | 达沙替尼 | 2 | 积极不招聘 | 1 |
| DB12282 | Defactinib | 2 | 积极不招聘 | 1 |
| DB12147 | Erdafitinib | 2 | 积极不招聘 | 1 |
| DB11795 | gsk - 2636771 | 2 | 积极不招聘 | 1 |
| DB11743 | Ipatasertib | 2 | 积极不招聘 | 1 |
| DB14723 | Larotrectinib | 2 | 积极不招聘 | 1 |
| DB15994 | 甲烷 | 2 | 积极不招聘 | 1 |
| DB09035 | Nivolumab | 2 | 积极不招聘 | 1 |
| DB09330 | Osimertinib | 2 | 积极不招聘 | 1 |
| DB09073 | Palbociclib | 2 | 积极不招聘 | 1 |
| DB09037 | Pembrolizumab | 2 | 积极不招聘 | 1 |
| DB06366 | Pertuzumab | 2 | 积极不招聘 | 1 |
| DB14851 | Relatlimab | 2 | 积极不招聘 | 1 |
| DB11836 | Sapanisertib | 2 | 积极不招聘 | 1 |
| DB14546 | 硫酸根离子 | 2 | 积极不招聘 | 1 |
| DB01268 | 舒尼替 | 2 | 积极不招聘 | 1 |
| DB12108 | Taselisib | 2 | 积极不招聘 | 1 |
| DB08911 | Trametinib | 2 | 积极不招聘 | 1 |
| DB00072 | 曲妥珠单抗 | 2 | 积极不招聘 | 1 |
| DB05773 | 曲妥珠单抗emtansine | 2 | 积极不招聘 | 1 |
| DB00135 | 酪氨酸 | 2 | 积极不招聘 | 1 |
| DB13930 | Ulixertinib | 2 | 积极不招聘 | 1 |
| DB08828 | Vismodegib | 2 | 积极不招聘 | 1 |